KMT2A-AFF1 (also called MLL-AF4) and KMT2A-MLLT3 (previously called MLL-AF9) fusion gene have been reported in ALL cases, while the KMT2A-MLLT3 fusion gene is a reverse factor of ALL cases [4, 5]. This evidence concerns the gene MLLT3 and acute lymphoblastic leukemia.